These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 26901400

  • 1. Molecular detection of intrauterine microbial colonization in women with endometriosis.
    Khan KN, Fujishita A, Masumoto H, Muto H, Kitajima M, Masuzaki H, Kitawaki J.
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():69-75. PubMed ID: 26901400
    [Abstract] [Full Text] [Related]

  • 2. Intra-uterine microbial colonization and occurrence of endometritis in women with endometriosis†.
    Khan KN, Fujishita A, Kitajima M, Hiraki K, Nakashima M, Masuzaki H.
    Hum Reprod; 2014 Nov; 29(11):2446-56. PubMed ID: 25205755
    [Abstract] [Full Text] [Related]

  • 3. Levofloxacin or gonadotropin releasing hormone agonist treatment decreases intrauterine microbial colonization in human endometriosis.
    Khan KN, Fujishita A, Muto H, Masumoto H, Ogawa K, Koshiba A, Mori T, Itoh K, Teramukai S, Matsuda K, Nakashima M, Kitawaki J.
    Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():103-116. PubMed ID: 34298448
    [Abstract] [Full Text] [Related]

  • 4. Effect of GnRH agonist therapy on the expression of human heat shock protein 70 in eutopic and ectopic endometria of women with endometriosis.
    Imamura T, Khan KN, Fujishita A, Kitajima M, Hiraki K, Ishimaru T, Masuzaki H.
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():16-23. PubMed ID: 25016551
    [Abstract] [Full Text] [Related]

  • 5. Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist.
    Manetta LA, de Paula Martins W, Rosa e Silva JC, de Sá Rosa e Silva AC, Nogueira AA, Ferriani RA.
    Ultrasound Med Biol; 2008 Dec; 34(12):1914-8. PubMed ID: 18597921
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial.
    Yamaguti EM, Brito MB, Ferriani RA, Garcia AA, Rosa-e-Silva JC, Vieira CS.
    Thromb Res; 2014 Dec; 134(6):1193-7. PubMed ID: 25283586
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Decreased Level of Neurotrophic Factor Neuritin 1 in Women with Ovarian Endometriosis after Receiving Gonadotropin-Releasing Hormone Agonist Treatment.
    Rahmawati E, Yang WV, Lei YP, Maurya PK, Chen HW, Tzeng CR.
    Int J Mol Sci; 2019 Sep 05; 20(18):. PubMed ID: 31491902
    [Abstract] [Full Text] [Related]

  • 11. Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis.
    Kim YA, Kim MR, Lee JH, Kim JY, Hwang KJ, Kim HS, Lee ES.
    Gynecol Obstet Invest; 2009 Sep 05; 68(2):73-81. PubMed ID: 19401614
    [Abstract] [Full Text] [Related]

  • 12. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
    Li Z, Zhang HY, Zhu YJ, Hu YJ, Qu PP.
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec 05; 183():164-8. PubMed ID: 25461372
    [Abstract] [Full Text] [Related]

  • 13. Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment.
    Nirgianakis K, Bersinger NA, McKinnon B, Kostov P, Imboden S, Mueller MD.
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct 05; 170(2):550-4. PubMed ID: 23993133
    [Abstract] [Full Text] [Related]

  • 14. The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis.
    Kim NY, Ryoo U, Lee DY, Kim MJ, Yoon BK, Choi D.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jan 05; 154(1):85-9. PubMed ID: 20832162
    [Abstract] [Full Text] [Related]

  • 15. High serum follistatin levels in women with ovarian endometriosis.
    Florio P, Reis FM, Torres PB, Calonaci F, Abrao MS, Nascimento LL, Franchini M, Cianferoni L, Petraglia F.
    Hum Reprod; 2009 Oct 05; 24(10):2600-6. PubMed ID: 19549703
    [Abstract] [Full Text] [Related]

  • 16. Gonadotropin-releasing hormone agonist induces downregulation of tensin 1 in women with endometriosis.
    Rahmawati E, Yang WV, Lei YP, Maurya PK, Chen HW, Tzeng CR.
    Acta Obstet Gynecol Scand; 2019 Feb 05; 98(2):222-231. PubMed ID: 30312486
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
    Surrey ES, Judd HL.
    J Clin Endocrinol Metab; 1992 Aug 05; 75(2):558-63. PubMed ID: 1386374
    [Abstract] [Full Text] [Related]

  • 20. Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo.
    Sesti F, Capozzolo T, Pietropolli A, Marziali M, Bollea MR, Piccione E.
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov 05; 147(1):72-7. PubMed ID: 19665279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.